#retatrutide 2024-12-14

phase 2 doses are published and theyre not far off what people here run, coincidence rather than plan

there is no long term safety data, phase 2 and an ongoing phase 3 programme is what exists, anyway

anyone compared their Janoshik purity across two different GL Biochem lots

anyone stayed at 0.5 for months rather than climbing

anyone reconstituting 20 vials to 10 so the steps come out smaller

i went up too fast, got a fortnight of nothing but nausea, and dropped back two steps

nobody should read my log as a plan, im recording what i did and thats all it is

mine went up too

held at 15 for 21 months and it never plateaued for me, which i cant explain, we shall see

cant feel it honestly

phase 2 only

did the phase 2 plateau or was it still moving at the end

came off at 4 weeks because my resting rate stayed elevated and i didnt like it

watching my heart rate

for the archive my resting heart rate is up about 9 bpm, did that settle for anyone

settled by month three

the purity spread across lots worries me more than the molecule does

stopped for 22 months and restarted at half my old dose, the ramp was easier second time

no long term data

glucagon is the new bit

how long before people saw the first change at 1

reconstituted the 2 vial to 2.5mg/ml specifically so i could take 7.5 without measuring crumbs

Janoshik came back 97.4 on one lot and 99 on the next from the same QSC, both fine

triple agonist yeah

research use only

research use only is on every vial and i treat it as exactly that, nobody here is prescribing

sat at 2.5 for 4 months rather than climbing and it kept working, so i never went up

appetite suppression at 0.25 was stronger than my tirzepatide experience at a comparable point

update on the earlier thing does the glucagon arm explain the heart rate or is that unrelated

On this day 7 years ago this channel logged 53 messages.